Efficacy and safety of QVA149 compared with salmeterol/fluticasone combination (SFC) in Chinese patients with moderate-to-severe COPD: A subgroup analysis from the LANTERN study

被引：0
|
作者：
Zhong, Nanshan [1 ]
Wang, Changzheng [2 ]
Zhou, Xiangdong [3 ]
Zhang, Nuofu [1 ]
Patalano, Francesco [4 ]
Humphries, Michael [5 ]
Wang, Linda [5 ]
Banerji, Donald [6 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[2] Third Mil Med Univ, Xin Qiao Hosp, Inst Resp Dis, Chongqing, Peoples R China
[3] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China
[4] Novartis Pharma AG, Resp, Basel, Switzerland
[5] Beijing Novartis Pharma Co Ltd, Resp, Beijing, Peoples R China
[6] Novartis Pharmaceut, Resp, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
COPD; -; manag; ement; Bronchodilators; Treatments;
D O I：
10.1183/13993003.congress-2015.PA990
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA990
引用
收藏
页数：2
相关论文
共 50 条
  • [41] SAFETY OF INDACATEROL/GLYCOPYRRONIUM (IND/GLY) COMPARED WITH SALMETEROL/FLUTICASONE (SFC) IN MODERATE-TO-VERY SEVERE COPD PATIENTS WITH PRIOR EXACERBATIONS: RESULTS FROM THE FLAME STUDY
    Wedzicha, J.
    Vestbo, J.
    Larbig, M.
    Fogel, R.
    Thach, C.
    Patalano, F.
    Banerji, D.
    RESPIROLOGY, 2016, 21 : 181 - 181
  • [42] Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma
    Corren, Jonathan
    Mansfield, Lyndon E.
    Pertseva, Tetyana
    Blahzko, Viktor
    Kaiser, Kirsten
    RESPIRATORY MEDICINE, 2013, 107 (02) : 180 - 195
  • [43] Dual Bronchodilation With QVA149 Improves Dyspnea in Patients With Moderate-to-Severe COPD: Pooled Analysis From the FLIGHT1 and FLIGHT2 Studies
    Mahler, Donald
    Larbig, Michael
    Patalano, Francesco
    Maitra, Samopriyo
    Banerji, Donald
    CHEST, 2015, 148 (04)
  • [44] QVA149 ONCE DAILY IMPROVES EXERCISE TOLERANCE AND LUNG FUNCTION IN PATIENTS WITH MODERATE TO SEVERE COPD: THE BRIGHT STUDY
    Beeh, K. M.
    Korn, S.
    Beier, J.
    Jadayel, D.
    Henley, M.
    Tylek, J.
    Berhane, I.
    D'Andrea, P.
    Banerji, D. Donald
    THORAX, 2012, 67 : A147 - A147
  • [45] QVA149 Improves Lung Function and Reduces Exacerbations Compared With Tiotropium in Patients With Severe-to-Very Severe COPD: The SPARK Study
    Ficker, Joachim
    Wedzicha, Jadwiga
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    CHEST, 2014, 145 (03)
  • [46] QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study
    Ficker, Joachim H.
    Wedzicha, Jadwiga A.
    Decramer, Marc
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [47] In Patients With More Severe Dyspnea, Dual Bronchodilation With Once-Daily Qva149 Improves Dyspnea, Health Status, And Lung Function Compared With Tiotropium And Salmeterol/fluticasone Combination: The Ignite Trials
    Mahler, D. A.
    D'Urzo, A. D.
    Keininger, D. L.
    Mezzi, K.
    Banerji, D. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [48] EFFICACY AND SAFETY OF ONCE-DAILY QVA149 COMPARED WITH THE FREE COMBINATION OF ITS MONO-COMPONENTS: THE BEACON STUDY
    Dahl, Ronald
    Jadayel, Dalal
    Alagappan, Vijay K. T.
    Banerji, Donald
    RESPIROLOGY, 2013, 18 : 130 - 130
  • [49] Cost-effectiveness of indacaterol/glycopyrronium in comparison with salmeterol/fluticasone combination for patients with moderate-to-severe chronic obstructive pulmonary disease: a LANTERN population analysis from Singapore
    Tee, Augustine
    Chow, Wai Leng
    Burke, Colin
    Guruprasad, Basavarajaiah
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (07) : 383 - 389
  • [50] ONCE-DAILY QVA149 PROVIDES SUPERIOR BRONCHODILATION AND IMPROVES LUNG FUNCTION VERSUS TWICE-DAILY FLUTICASONE/SALMETEROL IN COPD PATIENTS: THE ILLUMINATE STUDY
    Vogelmeier, C.
    Bateman, E.
    Pallante, J.
    Bryant, H.
    Alagappan, V.
    D'Andrea, P.
    He, E.
    Banerji, D.
    THORAX, 2012, 67 : A149 - A149
12345